Semnur Pharmaceuticals

Developing non-opioid therapeutics for management of back pain

Semnur is a specialty pharmaceuticals company advancing novel therapeutics for patients with chronic back pain. Over 80% of Americans are affected by back pain at some point in their lives, but there remain limited therapeutic options for these patients. Semnur's experienced team is advancing the company's lead asset to meet the unmet need of back pain through innovation.

Status
Merger with Scilex Pharmaceuticals in 2018
Year of Investment
2013
Strategy
Life Sciences
Location
Los Altos, California